Intervention

Auranofin

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions11

Lead sponsors shown3

Clinical trials

4 shown

Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without AntiretroviralsNCT06805656 · 2026-07-15

Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing CureNCT02961829 · 2015-07-01

Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung CancerNCT01737502 · 2014-05-14

Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV InfectionNCT02176135

Common conditions

Hiv3 Chronic Infection1 Extensive Stage Small Cell Lung Carcinoma1 HIV I Infection1 Lung Adenocarcinoma1 Recurrent Non-Small Cell Lung Carcinoma1 Recurrent Small Cell Lung Carcinoma1 Squamous Cell Lung Carcinoma1 Stage IIIA Non-Small Cell Lung Cancer1 Stage IIIB Non-Small Cell Lung Cancer1 Stage IV Non-Small Cell Lung Cancer1

Leading sponsors

Federal University of São Paulo2 Mayo Clinic1 Vaccine and Gene Therapy Institute, Florida1

Trial status mix

COMPLETED2

RECRUITING1

WITHDRAWN1

Phase mix

PHASE23

PHASE12

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.